Serum immunoreactive erythropoietin in patients with end stage renal disease.
Gimenez
L F
LF
Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Watson
A J
AJ
Spivak
J L
JL
D000740:Anemia / Q000097:blood / Q000209:etiology*; D003404:Creatinine / Q000097:blood; D004921:Erythropoietin / Q000097:blood* / Q000172:deficiency; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000150:complications / Q000628:therapy; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D006435:Renal Dialysis / Q000009:adverse effects
D006454:Hemoglobins; D004921:Erythropoietin; D003404:Creatinine